Upload
others
View
5
Download
0
Embed Size (px)
Citation preview
Metabolism of pentoses,
glycogen, fructose and
galactose
Karel Kotaska
1. The Pentose Phosphate
Pathway
The pentose phosphate pathway (PPP): (hexose monophosphate or 6-phosphogluconate patway)
• Process that generates NADPH and pentoses (5-carbon sugars).
• Enzymes are located in the cytosol
• Rapidly dividing cells (bone marrow, skin, intestinal mucosa, tumors) ribose 5-phosphate RNA, DNA.
• Other tissues NADPH electron donor for reductive biosynthetic reactions
– fatty acids synthesis (liver, adipose tissue),
– cholesterol and steroid hormones synthesis (liver, adrenal glands, gonads)
– elimination of oxygen radicals effects (erythrocytes).
The pentose phosphate pathway (PPP)
Oxidation
Isomerization
and epimerization
C-C bond cleaving and formation
Regulation:
Glucose 6-phosphate dehydrogenase
• inhibition - by NADPH
• induction - by insulin/glucagon ↑
1. The oxidative phase of PPP:
Oxidative (irreversible) products:
→ ribose 5-phosphate (nucleotide
synthesis)
→ NADPH (fatty acid synthesis,
detoxification, reduction of
glutathion)
Some concepts
• Isomers - molecules with the same molecular formula but different chemical structures (glucose and fructose)
• Epimers - differ at only one chiral center, not the anomeric carbon.
• Enantiomers - chiral molecules that are mirror images of one another.
Epimers Enantiomers
2. The nonoxidative phase of PPP:
Nonoxidative (reversible)
→ conversion of ribose 5-phosphate to intermediates of glycolysis
→ production of ribose 5-phosphate from intermediates of glycolysis
Transketolase mechanism
E - transketolase
Transaldolase metabolism
Relationship between glycolysis
and pentose phosphate pathway
Pathways that require NADPH:
Detoxification
• reduction of oxidized glutathione
• cytochrome P450 monooxygenases
Reductive synthesis
• fatty acid synthesis
• fatty acid chain elongation
• cholesterol synthesis
• steroid hormon synthesis
• neurotransmitter synthesis
• deoxynucleotide synthesis
Summary of the pathways requiring NADPH+
The role of PPP
in maintenance of the erythrocyte
membrane integrity
-Antioxidant
-Xenobiotic metabolism
-Amino acid transport
PPP in liver
Clinical correlations:
Treatment by certain drugs (i.e. sulfonamides)
people with glucose 6-phosphate dehydrogenase deficiency (7% of
the world population)
increased production of free radicals
reduced protection of erythrocytes against FR
hemolysis, hemoglobinuria, hemolytic anemia
Fava beans
Favism
Summary
The pentose phosphate pathway
A shunt from glycolysis
Production of NADPH (reductive syntheses, detoxifications),
ribose 5-phospate
Conversion to intermediates of glycolysis
Isomerases, epimerases, transketolases, transaldolases
Glucose 6-phosphate dehydrogenase deficiency
2. Metabolism of glycogen
Glycogen metabolism
Glycogen
• The glycogen – a storage form of glucose
• Required as a ready source of energy
• The liver – tremendous capacity for storing glycogen – 10% of the wet weight
• Muscle – max.1 – 2% of the wet weight
• Muscle and liver glycogen stores serve completely different roles:
– muscle glycogen – fuel reserve for ATP synthesis
– liver glycogen – glucose reserve for the maintenance of blood glucose concentration
Glycogen storage during the day
Glucosyl units of α-D-glucose linked by α-1,4 and α-1,6 link (branching every 8-10
units)
source of energy in animals (liver, muscles)
highly branched structure (rapid degradation and synthesis, better solubility)
Nonreducing end
glycogenin
Glycogen
Glycogen
UDP-glucose – the substrate for glycogen synthesis and UDP is released as a
reaction product
glucose-1-phosphate + UTP UDP-glucose + PPi
PPi + H2O 2 Pi
Overall: glucose-1-phosphate + UTP UDP-glucose + 2 Pi
Cleavage of PPi is the only energy cost for glycogen synthesis (one ~P
bond per glucose residue).
Glycogen synthesis
Glycogenin - (enzyme) initiates glycogen synthesis.
Glycogen synthesis
Glycogen synthesis:
A glycogen primer - 4 attached glucose
molecules to glycogenin
- not degraded
- synthesis autocatalytic glycosylation,
autophosphorylation of glycogenin)
Transfer of 6-8 units
Glycogen synthase (regulation)
An energy-requiring pathway (UTP)
Chain cleavage (phosphorolysis) –
glycogen phosphorylase
- to 4 units from a branch point
-The debrancher enzyme - amylo-16
glukosydase (transfer of 3 units, hydrolysis of 1
glucose)
-two catalytic activities – transferase + a-16-
glucosydase
Glycogen phosphorylase (regulation)
Glycogen degradation:
The glycogen metabolism in the muscles and the liver:
Decrease in glucose in the blood
→ glycogen degradation
→ release of glucose to the blood
Glucose 6-phosphatase (only in
liver)
High ATP demand
→ glycogen degradation
→ anaerobic glycolysis
The glycogen metabolism in the muscles and the liver:
Regulation of glycogen
metabolism
Glycogen synthase
Covalent modification
Regulation of glycogen synthesis and degradation in the liver
Activation of muscle glycogen phosphorylase
during exercise
Regulation of phosphatase-1 in
muscle
Regulation of
glycogensynthase in muscle
Hormonal control of
glycogene metabolism
Regulation of
glycogenphosphorylase in muscle
Regulation of glycogen synthesis and degradation
Phosphorylation and
dephosphorylation in muscles
Control of glycolysis and
glycogenesis
cAMP dependent protein kinase
State Regulators Response
Liver
Fasting Glucagon ↑, Insulin ↓
cAMP ↑
Glycogen degradation ↑
Glycogen synthesis ↓
Carbohydrate meal Glu ↑, Glucagon ↓, Insulin ↑
cAMP ↓
Glycogen degradation ↓
Glycogen synthesis ↑
Exercise and stress Adrenalin ↑
cAMP ↑, Ca2+-calmodulin ↑
Glycogen degradation ↑
Glycogen synthesis ↓
Muscle
Fasting (rest) Insulin ↓ Glycogen synthesis ↓
Glucose transport ↓
Carbohydrate meal (rest) Insulin ↑ Glycogen synthesis ↑
Glucose transport ↑
Exercise Epinephrine ↑
AMP ↑, Ca2+-calmodulin ↑,
cAMP ↑
Glycogen synthesis ↓
Glycogen degradation ↑
Glycolysis ↑
Regulation of liver and muscle glycogen metabolism:
Clinical correlations:
Maternal malnutrition in the last trimester of pregnancy
(physiologically: glycogen formation and storage during the
last 10 weeks of pregnancy by the fetus → reserve for first
hours → prevention of hypoglycemia)
reduced or no glycogen reserve in the fetus
after birth → hypoglycemia, apathy, coma
Type Enzyme affected Genetics Organ
involved
Manifestations
I (Von Gierke´s
disease)
Glucose 6-
phosphatase
AR
(1/200 000)
Liver Hypoglycemia, lactate
acidosis, hyperlipidemia,
hyperuricemia.
Enlarged liver and kidney.
II (Pompe
disease)
Lysosomal α-1,4-
glucosidase
AR Organs
with
lysosomes
Glycogen deposits in
lysosomes.
Hypotonia, cardiomegaly,
cardiomyopathy (Infantile f.).
Muscle weakness (Adult f.)
III (Cori´s
disease)
The debrancher
enzyme
AR Liver,
muscle,
heart
Hepatomegaly,
hypoglycemia
V (McArdle
disease)
Muscle glycogen
phosphorylase
AR Muscle Exercise-induced muscular
pain, cramps, muscle
weakness
Glycogen storage diseases:
G6P Deficiency
Summary:
Glycogen metabolism
Different role of glycogen stores in the liver and muscles
Glycogen synthesis and degradation are separate pathways
(regulation)
Glycogen storage diseases
3. Fructose Galactose and
other hexoses metabolism
Fructose metabolism
Fructose metabolism
Essential
fructosuria
Hereditary fructose
intolerance
Fructose metabolism
Adequate diet Low glucose
Aldolase A: in all tissues
(small intestine, kidney)
Aldolase B: low affinity for
fructose 1-phosphate (→
accumulation of fructose
1-phosphate in the liver )
Fructose metabolism in muscle
The polyol pathway
Seminal vesicles (spermatozoa use fructose)
Accumulation of sorbitol in diabetic patients
Lens (diabetic cataract)
Muscles, nerves (periferal neuropathy)
Lens metabolism:
Diabetic cataract :
↑glucose concentration in the lens → ↑aldose reductase activity → sorbitol
accumulation → ↑osmolarity, structural changes of proteins
Galactose metabolism:
Liver
Lactating mammary gland
Other aspects of metabolism Amino-sugar synthesis Uronic acid pathway
Nucleotide sugars
Glycosyl donors in oligosacharide biosynthetic reactions (glycosyltransferases)
O – linked oligosacharides
N- linked oligosacharides
Interrelationships in aminosugar metabolism
Clinical correlations:
A newborn: failure to thrive, vomiting and diarrhea after milk
galactosemia (Galactose 1-phosphate uridylyltransferase
deficiency)
genetic disease (AR, 1/60 000)
hepatomegaly, jaundice, cataracts, mental retargation, death
Management: early diagnose, elimination of galactose from the diet
(artificial milk from soybean hydrolysate)
Summary:
Fructose and Galactose metabolism
Conversion to intermediates of glycolysis
Genetic abnormalities, accumulation of intermediates, tissue
damage
Accumulation of sorbitol in diabetes
Pictures used in the presentation
1. Marks´ Basic Medical Biochemistry A Clinical Approach, third edition, 2009 (M.
Lieberman, A.D. Marks)
2. Textbook of Biochemistry with Clinical Correlations, sixth edition, 2006 (T.M. Devlin)
3. Meissenberg and Simmons: Principles of Medical Biochemistry, 3rd Edition, 2012
4.Voet, Voet and Pratt: Fundamentals of Biochemistry –Life at the molecular level 4th
Ed, 2013
5. Rodwell, V., Bender, D., et al.: Harpers Illustrated Biochemistry 30th Ed, 2015.
6. Salway, JG. Metabolism At a Glance 4th Edition, 2017